NCT07303465
- Conditions
- KRAS G12D Mutations, Pancreatic Ductal Adenocarcinoma (PDAC)
- Locations
-
- Nanjing Tianyinshan Hospital Nanjing, China
- Shanghai GoBroad Cancer Hospital China Pharmaccutical University Shanghai, China
Clinical trial condition
KRAS G12D Mutations
Explore clinical trials studying KRAS G12D Mutations. Study availability and eligibility vary by location and protocol.
2 public trials
2 recruiting studies
KRAS G12D Mutations trial results
NCT06500676
- Conditions
- Advanced Solid Tumors, KRAS G12D Mutations
- Locations
-
- The First Affiliated Hospital of Anhui Medical University Hefei, Anhui, China
- Cancer Hospital, Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China
- Peking Union Medical College Hospital Beijing, Beijing Municipality, China
- Sun Yat-sen Memorial Hospital, Sun Yat-sen University Guangzhou, Guangdong, China